knowledge -WSS

knowledge

author：hotspot 2025-09-29 01:36:11 - browse：725

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Caitlin Bernard's story shows physicians can't shy from advocacy

WSS

Why an extreme heat and wildfire smoke combination can be so dangerous

Diverse clinical trials: Why aren’t we there yet?

A common UTI test for kids haunts adults as a traumatic 'nightmare'

HIPAA doesn't protect reproductive records from prosecutors

Court strikes down limits on filming of police in Arizona

Review: 'Barbie' will hit you like a shot in the heart

hotspot

knowledge

leisure time

Drug repurposing or repositioning? The language matters

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Medical leaders decry Supreme Court decision on affirmative action

Will the IRA bring competition to the biologics market?

Tori Bowie and the unacceptable rates of Black maternal death

A double vaccine crisis is endangering millions of children

Peter Hotez and the public health issue of online harassment

FDA panel endorses Alnylam’s heart drug — after picking it apart

ChatGPT in medicine: STAT answers readers' burning questions

As Taiwan prepares for anti

knowledge

Long Covid needs a new name — and a new frame

How artificial intelligence is being used to detect, treat cancer

Diverse clinical trials: Why aren’t we there yet?

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Elizabeth Warren probes abortion access

Will the IRA bring competition to the biologics market?

explore

focus

Wikipedia

Wikipedia